4DMedical Limited (ASX:4DX) Lodges Supplementary Prospectus
4DMedical Limited (ASX:4DX) lodges a supplementary prospectus amending the terms of its New and Piggyback Options offers.
4DMedical Limited (ASX:4DX) lodges a supplementary prospectus amending the terms of its New and Piggyback Options offers.
Rio Tinto (ASX:RIO) reports a 16% increase in Q1 copper production and records in bauxite, alongside progress in key growth projects.
Air New Zealand (ASX:AIZ) projects earnings before tax between $150M and $190M for 2025 amid lower compensation from engine manufacturers.
The Star Entertainment Group (ASX:SGR) reinstates trading suspension, resuming on April 16 after lodging its Appendix 4D and half-year financial report.
Green Critical Minerals (ASX:GCM) advances its VHD Graphite technology with customer testing and first heat sink production, enhancing market validation.
360 Capital Group (ASX:TGP) announces an off-market buy-back of up to 15.4% of its securities at $0.65 per security.
Hancock & Gore Limited (ASX:HNG) reports a 3% sales increase in H1 FY25 and announces a forthcoming dividend declaration.
Helios Energy Ltd (ASX:HE8) completes its entitlement offer, successfully raising $2.6 million to advance the Presidio Project.
Pro Medicus Limited (ASX:PME) enters a multi-year AI research collaboration with UCSF to advance healthcare imaging solutions.
EBR Systems (ASX:EBR) proposes CMS approval of NTAP reimbursement for its WiSE CRT System, advancing US market strategy.